- Home
- ESGL vs DTIL Comparison
ESGL vs DTIL Comparison
Compare ESGL & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESGL
- DTIL
- Stock Information
- Founded
- ESGL 1999
- DTIL 2006
- Country
- ESGL Singapore
- DTIL United States
- Employees
- ESGL N/A
- DTIL N/A
- Industry
- ESGL
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- ESGL
- DTIL Health Care
- Exchange
- ESGL Nasdaq
- DTIL Nasdaq
- Market Cap
- ESGL 52.2M
- DTIL 44.1M
- IPO Year
- ESGL N/A
- DTIL 2019
- Fundamental
- Price
- ESGL $1.09
- DTIL $5.04
- Analyst Decision
- ESGL
- DTIL Strong Buy
- Analyst Count
- ESGL 0
- DTIL 3
- Target Price
- ESGL N/A
- DTIL $37.67
- AVG Volume (30 Days)
- ESGL 19.5K
- DTIL 1.2M
- Earning Date
- ESGL 03-03-2025
- DTIL 11-04-2024
- Dividend Yield
- ESGL N/A
- DTIL N/A
- EPS Growth
- ESGL N/A
- DTIL N/A
- EPS
- ESGL N/A
- DTIL 1.45
- Revenue
- ESGL $6,218,838.00
- DTIL $75,096,000.00
- Revenue This Year
- ESGL N/A
- DTIL $51.35
- Revenue Next Year
- ESGL N/A
- DTIL N/A
- P/E Ratio
- ESGL N/A
- DTIL $3.37
- Revenue Growth
- ESGL 20.34
- DTIL 43.62
- 52 Week Low
- ESGL $0.41
- DTIL $3.61
- 52 Week High
- ESGL $2.23
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- ESGL 33.04
- DTIL 47.66
- Support Level
- ESGL $1.20
- DTIL $4.50
- Resistance Level
- ESGL $2.09
- DTIL $7.44
- Average True Range (ATR)
- ESGL 0.19
- DTIL 0.58
- MACD
- ESGL -0.02
- DTIL 0.09
- Stochastic Oscillator
- ESGL 2.81
- DTIL 16.33
About ESGL ESGL Holdings Limited
ESGL Holdings Ltd Formerly Environmental Solutions Group Holdings Ltd is a waste management, treatment and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical and electroplating companies.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.